Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 521 of 1,261
  1. US 10188714

    Yeast-MUC1 immunotherapeutic compositions and uses thereof

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  2. US 10188711

    Peptide conjugated particles

    Northwestern University · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  3. US 10188656

    Methods of treatment of malignancies

    Agios Pharmaceuticals, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  4. US 10188650

    Treatment of neurological disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  5. US 10188704

    Enhanced melanoma cancer prevention by novel melanotropins

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  6. US 10188654

    Uses of pyrimido-pyridazinones to treat cancer

    Asana BioSciences, LLC · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  7. US 10188648

    Solid state forms of selexipag

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  8. US 10188811

    Nasal spray device

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  9. US 10188635

    Use of gaboxadol in the treatment of tinnitus

    OVID THERAPEUTICS INC. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  10. US 10188614

    Particulate materials

    Nektar Therapeutics · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  11. US 10188461

    Selective fat removal using photothermal heating

    The Regents of the University of California · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  12. US 10188608

    Oxidized cellulose microspheres

    Covidien LP · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  13. US 10188135

    Method for inducing satiety

    Stokely-Van Camp, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  14. WO 2019016609

    TRAITEMENT DE LÉSIONS NON INFLAMMATOIRES

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 24, 2019 · Expires Jan 19, 2039

    granted
  15. CA 3070264

    ASSOCIATIONS PHARMACEUTIQUES COMPRENANT UN ANTICORPS ANTI-BST-1 ET UN ANALOGUE DE CYTIDINE

    BERLIN CHEMIE AG [DE] · Granted Jan 24, 2019 · Expires Jan 19, 2039

    granted
  16. WO 2019016112

    COMPOSÉS DE QUINOLÉINE À SUBSTITUTION EN POSITIONS 1, 2, 3 ET 4 UTILISÉS EN TANT QUE MODULATEURS DE S1P

    ABBVIE DEUTSCHLAND [DE] · Granted Jan 24, 2019 · Expires Jan 19, 2039

    granted
  17. US 10183080

    Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted
  18. US 10183942

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted
  19. US 10183917

    Tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted
  20. US 10183011

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted
  21. US 10183944

    Pyrimido-pyridazinone compounds and methods of use thereof

    Asana BioSciences, LLC · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted
  22. US 10183021

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted
  23. US 10183033

    Triptolide prodrugs

    Regents of the University of Minnesota · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted
  24. US 10182979

    Biodegradable microspheres

    Regents of the University of Minnesota · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.